Are Health Care Organizations Ready for Generative AI?

Get your free report today!

Generative artificial intelligence (GenAI) promises to deliver transformational innovation and efficiency across a range of clinical, operational, and technical processes within health care. To achieve these benefits, provider organizations will be challenged to more fully embrace new digital technologies and invest resources in the advanced data management capabilities, updated IT infrastructure, and internal expertise that will be necessary. These are among the findings of a July 2024 survey of the NEJM Catalyst Insights Council. There is broad consensus among survey respondents that GenAI will have a big impact on health care delivery over the next few years. Yet few health care organizations are ready for adoption today.

Download this free report to see the full results of this survey.

Brought to you as a professional courtesy by Deloitte Life Sciences & Health Care Practice.

About Deloitte’s Life Sciences & Health Care Practice

Throughout the health ecosystem, you’ll find courageous and inspiring people who are committed to driving transformation, advancing health equity, and leading a well-being revolution. Where you find innovators committed to sustainable progress, you’ll find Deloitte’s Life Sciences & Health Care practice. Our leaders work side-by-side to orchestrate and deliver on the business of science and health. We bring trusted, flexible approaches that foster innovation, harness new technologies, and formulate consumer-driven strategies to engineer a digitally enabled, equitable future of health – starting today. For more insights from Deloitte’s Life Sciences and Health Care practice, visit www.deloitte.com/us/lifesciencesandhealthcare and www.deloitte.com/us/industry-advantage.